2-oxindole has been researched along with Ductal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, S; Azmi, AS; Banerjee, S; Bao, B; Beck, FW; Choi, M; Maitah, M; Mohammad, RM; Philip, PA; Sarkar, FH; Shields, TF; Wang, Z | 1 |
1 other study(ies) available for 2-oxindole and Ductal Carcinoma
Article | Year |
---|---|
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ductal; Cell Line, Tumor; Computational Biology; Computer Simulation; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Drug Synergism; Early Growth Response Protein 1; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Indoles; Microarray Analysis; Molecular Targeted Therapy; Organoplatinum Compounds; Oxaliplatin; Oxindoles; Pancreatic Neoplasms; Platinum Compounds; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Spiro Compounds; Transcription Factors; Tumor Suppressor Protein p53 | 2011 |